Bioresorbable Scaffold Technologies
スポンサーリンク
概要
- 論文の詳細を見る
Fully bioabsorbable scaffolds (BRS) are a novel approach that provides transient vessel support with drug delivery capability without the long-term limitations of the metallic drug-eluting stents (DES), such as permanent caging with or without malapposition. The technology has the potential to overcome many of the safety concerns associated with metallic DES, and possibly even convey further clinical benefit. Although the technology is still in its infancy, several devices have been tested in clinical trials and the initial results have been very promising. This review will discuss the emerging need for BRS, the theoretical advantages of this new technology over current generation metallic DES and review the status of the currently available BRS. In addition, we will discuss the ideal duration of bioresorption, the proven and potential clinical benefits and future perspectives of this rapidly progressing technology. (Circ J 2011; 75: 509-520)
- 2011-02-25
著者
-
ORMISTON John
Auckland City Hospital
-
Serruys Patrick
Erasmus University Medical Center Rotterdom Kingdom Of Netherlands
-
Onuma Yosinobu
Erasmus Medical Center
-
Serruys Patrick
Erasmus Medical Center
関連論文
- Short- and Mid-Term Intravascular Ultrasound Analysis of the New Zotarolimus-Eluting Stent With Durable Polymer : Results From the RESOLUTE Trial
- Bioresorbable Scaffold Technologies
- Comparison of Vascular Response to Zotarolimus-Eluting Stent vs Paclitaxel-Eluting Stent Implantation : Pooled IVUS Results From the ZoMaxx I and II Trials
- 1 Optimal Revascularization Strategies in Patients with Total Occlusions : 1-year Results from the SYNTAX Trial(Late Breaking Clinical Trials II,The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- Bioresorbable Scaffold Technologies
- Spatial Distribution and Temporal Evolution of Scattering Centers by Optical Coherence Tomography in the Poly (L-Lactide) Backbone of a Bioresorbable Vascular Scaffold
- Vascular Compliance Changes of the Coronary Vessel Wall After Bioresorbable Vascular Scaffold Implantation in the Treated and Adjacent Segments